Psychophysiological effects of dance/movement therapy on anxiety reduction in adolescents in juvenile detention centers: dopamine and thermoregulatory responses in a controlled study Authors: You-Jeong Nam, Eon-Ah Choo, Seunghyun Lee, Seunghyun Na, Young-Hyun Jung, Hwa-Young Lee, Jeong-Beom Lee Published: 2026 ABSTRACT BackgroundAnxiety among adolescents has increased globally during the COVID-19 pandemic. Adolescents in juvenile detention centers (JDCs) may be particularly vulnerable due to restricted liberty and social isolation. Movement-based interventions such as Dance/Movement Therapy (DMT) have been studied as approaches to support emotional regulation. This exploratory study investigated the psychophysiological effects of a structured DMT intervention on anxiety reduction among adolescents in JDCs, focusing on anxiety-related changes in dopamine (DA) levels and body temperature.MethodsThis quasi-experimental study included 55 female adolescents from a single juvenile detention center. Participants were allocated to either a non-DMT control group (n = 30, 16.17 ± 1.73 years), which maintained their usual institutional routine throughout the 8-week study period, or a DMT group (n = 25, 16.23 ± 1.68 years) that completed 24 DMT sessions over the same period. Anxiety and physiological measures were assessed before and after the intervention. Anxiety was measured using the Beck Anxiety Inventory (BAI). Physiological measures included mean body temperature (mTb), calculated from tympanic (core) and skin temperature measurements, and plasma DA levels measured using high-performance liquid chromatography (HPLC).ResultsFollowing the intervention, the DMT group showed a significant reduction in BAI scores (-16%, p < 0.001), along with significant increases in mTb (0.11 ± 0.07 °C, p < 0.001) and DA levels (+ 30%, p < 0.001). BAI scores were negatively correlated with mTb and DA levels, whereas mTb was positively correlated with DA levels.ConclusionsThis study provides preliminary evidence that DMT may help alleviate anxiety and support psychophysiological regulation among adolescents in JDCs. However, the exploratory design, single-center setting, and all-female sample may limit generalizability. Future multi-center studies with more diverse samples are needed to confirm these findings and clarify the underlying mechanisms.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s13034-026-01091-8. Introduction About 14% of adolescents aged 10 to 19 worldwide experience a mental disorder [1], with anxiety being the most common. During the Coronavirus Disease 2019 (COVID-19) pandemic, anxiety prevalence in adolescents increased to 20.5% [2]. Common symptoms include difficulty in controlling worry and concentrating, restlessness, fear, hypersensitivity, and sleep disturbances [3]. These symptoms are often associated with uncertainty, confusion in daily lives, health concerns [2], and stress [4]. Adolescents in detention and correctional facilities demonstrate substantially higher rates of mental disorders, including anxiety and major depression, compared with the general adolescent population [5]. Mental health conditions such as anxiety, depression, and attention-deficit/hyperactivity disorder are also associated with crime, detention, and antisocial behavior [6]. These findings highlight the need for mental health interventions tailored to adolescents in juvenile detention centers (JDCs), where restricted freedom, social isolation, and institutional stress may exacerbate anxiety. In this context, adolescents in South Korean JDCs constitute an important population for examining such interventions, as these settings enable the systematic and consistent delivery of mental health programs. Juvenile correctional institutions typically operate separate facilities for males and females, making mixed-gender interventions generally impractical. In addition, anxiety symptoms are more prevalent among females than males [7, 8], potentially due to biological susceptibility, lower baseline self-esteem, greater vulnerability to interpersonal violence, and stress related to gender inequality [9]. Therefore, the present study focused on female adolescents in JDCs. The World Health Organization emphasizes that adolescent mental health care should prioritize non-pharmacological approaches and avoid excessive medicalization [1]. In this context, dance/movement therapy (DMT) may be particularly suitable for detention settings. DMT is a psychotherapeutic approach that uses movement and is grounded in the mind–body connection and the healing potential of dance [10]. It combines elements of exercise, art, and recreation [11, 12], and may also be conceptualized as a multifaceted form of physical activity (PA). DMT promotes emotional, cognitive, and social integration to enhance health and well-being [13, 14]. Core features of dance, such as mirroring, synchrony, rhythm, and reciprocal movement, may promote emotional expression, self-awareness, empathy, and social connectedness [15, 16]. These characteristics may be particularly valuable in detention environments, where opportunities for self-expression and positive interpersonal interaction are often limited. Dance-based interventions may reduce anxiety more effectively than some other forms of PA by engaging reward-related neural pathways and supporting emotional regulation [17]. The potential anxiolytic effects of DMT may be partly explained by psychophysiological regulation. Anxiety is an adaptive response to threat involving multiple brain regions, including the amygdala, hippocampus, and prefrontal cortex (PFC) [18, 19]. However, excessive or dysregulated anxiety may increase vulnerability to mental health problems [20]. Neurotransmitter systems play an important role in this process [21], with dopaminergic signaling being particularly relevant to PFC function [22] and anxiety-related processes [23]. Dopamine (DA) is involved in motivation, reward processing, stress responsivity, and prefrontal regulatory function. Its mesolimbic pathway to the nucleus accumbens (NAc) has also been implicated in aversive conditioning and generalized anxiety [24]. PA and exercise may influence dopaminergic pathways [25] involved in reward processing and emotional regulation [26]. Increased DA levels have been associated with thermoregulation [27, 28], and reduced anxiety [29], suggesting a plausible neurobiological mechanism through which DMT may exert anxiolytic effects. Thermoregulation may represent another relevant pathway linking DMT and anxiety. Body temperature is regulated by the hypothalamus [30], and is closely linked to metabolic and autonomic function [31]. Physical exercise commonly elevates core body temperature [32, 33], accompanied by autonomic adjustments that may help reduce muscular tension and influence central nervous system activity related to anxiety regulation [34]. Higher body temperature has also been associated with more positive affect and fewer symptoms of depression and anxiety [35]. Together, these findings suggest that dopaminergic and thermoregulatory mechanisms may be interrelated components of the psychophysiological changes associated with movement-based intervention. Accordingly, mean body temperature (mTb) was included as a physiological indicator of thermoregulatory and autonomic responses potentially related to anxiety reduction during DMT. In the present study, blood DA levels were used as an exploratory peripheral biomarker because direct assessment of central dopaminergic activity was not feasible in juvenile detention settings. Although peripheral DA does not directly reflect central neurotransmission, it may provide preliminary information on systemic psychophysiological changes associated with emotional regulation. Despite growing evidence for the psychological benefits of DMT, little is known about its effects on anxiety, blood DA, and mTb in detained adolescents. To our knowledge, no previous study has examined these outcomes simultaneously in this population. This gap is important because detention settings involve distinctive psychosocial stressors, and the psychophysiological correlates of DMT in this population remain insufficiently understood. We hypothesized that DMT would be associated with reduced anxiety and concurrent changes in blood DA and mTb among adolescents in JDCs. To examine this hypothesis, we assessed anxiety using the Beck Anxiety Inventory (BAI) and measured mTb and blood DA levels before and after DMT. Materials and methods Participants A total of 55 female adolescents in the JDC participated in this study, conducted from November 2020 to November 2021, including Non-DMT control group (n = 30, 16.17 ± 1.73 years) and DMT group (n = 25, 16.23 ± 1.68 years) which underwent 24 DMT sessions over 8 weeks. General physical characteristics of the participants are summarized in Table 1. All female adolescents were imprisoned in the JDC in Chungcheongbuk-do, Republic of Korea. Inclusion criteria were as follows: (1) female Adolescents in JDCs who had been confined in a juvenile correctional facility for more than two months; (2) those who consistently exhibited behavioral and emotional difficulties during the mental and physical health promotion program and reported anxiety symptoms; (3) individuals without physical or cognitive impairments that would prevent participation in DMT; (4) those with no risk of leaving the juvenile center for up to two years after receiving a No. 10 protection disposition; and (5) those not currently participating in other treatment programs more than once per week. Exclusion criteria included participants who missed more than three DMT sessions, as insufficient attendance could limit exposure to the intervention and compromise the evaluation of treatment effects. Participants who declined or did not complete the psychological and physiological assessments were also excluded. Participant recruitment was conducted from November 2020 to May 2021, and the intervention and follow-up assessments were completed within the overall study period. All participants were provided with a detailed explanation of the study purpose, experimental procedures, and potential risks prior to enrollment. Written informed consent was obtained from each participant and their legal guardian(s). The study and all experimental procedures were conducted with the approval and cooperation of the institutional authorities responsible for the juvenile detention facility. Participants were informed that they could withdraw from the study at any time without any disadvantage. Table 1Physical characteristics of female adolescents in a juvenile detention center (n = 55)Variable (unit)Control groupExperimental groupNon-DMT G (n = 30)DMT G (n = 25)Age (year)16.17 ± 1.7316.23 ± 1.68Height (cm)157.83 ± 4.93157.69 ± 4.87Weight (kg)56.98 ± 6.2457.63 ± 8.49BSA (m2)1.57 ± 0.111.58 ± 0.13BMI (kg/m2)23.09 ± 2.1823.18 ± 2.04Values are presented as mean ± SD. No significant differences were found between the DMT and Non-DMT groups at baseline. BSA was calculated using the Du Bois formula [36]. JD, juvenile delinquents; DMT, dance movement therapy; Non-DMT G (Non-DMT group); DMT G (DMT group); BSA, body surface area; BMI, body mass index (InBody 520, Seoul, Republic of Korea) Table 1Physical characteristics of female adolescents in a juvenile detention center (n = 55)Variable (unit)Control groupExperimental groupNon-DMT G (n = 30)DMT G (n = 25)Age (year)16.17 ± 1.7316.23 ± 1.68Height (cm)157.83 ± 4.93157.69 ± 4.87Weight (kg)56.98 ± 6.2457.63 ± 8.49BSA (m2)1.57 ± 0.111.58 ± 0.13BMI (kg/m2)23.09 ± 2.1823.18 ± 2.04Values are presented as mean ± SD. No significant differences were found between the DMT and Non-DMT groups at baseline. BSA was calculated using the Du Bois formula [36]. JD, juvenile delinquents; DMT, dance movement therapy; Non-DMT G (Non-DMT group); DMT G (DMT group); BSA, body surface area; BMI, body mass index (InBody 520, Seoul, Republic of Korea) Physical characteristics of female adolescents in a juvenile detention center (n = 55) Values are presented as mean ± SD. No significant differences were found between the DMT and Non-DMT groups at baseline. BSA was calculated using the Du Bois formula [36]. JD, juvenile delinquents; DMT, dance movement therapy; Non-DMT G (Non-DMT group); DMT G (DMT group); BSA, body surface area; BMI, body mass index (InBody 520, Seoul, Republic of Korea) Sample size This quasi-experimental study was conducted in a juvenile detention center, where purposive sampling was used due to institutional constraints. Participants were allocated 1:1 to the DMT or Non-DMT group based on program availability rather than randomization. The required sample size was calculated a priori using G*Power (α = 0.05, power = 0.80) with an expected effect size of 0.75, based on previous DMT studies [10, 37]. The minimum required total sample size was estimated to be 58 participants (29 per group). The selected effect size corresponds to a medium-to-large effect according to Cohen’s criteria and is supported by previous empirical findings [10, 38]. Meta-analytic findings report large effects of dance-based interventions in adolescents (d ≈ 0.93) [10], while clinical DMT studies show effects ranging from 0.60 to 0.79 [37]. Based on this evidence, an effect size of 0.75 was considered a conservative and empirically supported estimate. Although the power calculation guided planning, actual recruitment was constrained by participant availability within the detention facility, making the calculation a reference rather than a strict determinant of final sample size. To account for attrition, the recruitment target was increased by 20%, resulting in an initial sample of 70 enrolled participants who were allocated to the DMT group (n = 35) and the Non-DMT control group (n = 35). Ten participants in the DMT group were excluded from the final analysis: five discontinued therapy, two were affected by COVID-19, and three were excluded due to institutional or legal constraints. In the Non-DMT control group, five participants were lost to follow-up, including three who withdrew consent and two who could not complete follow-up assessments due to institutional constraints. The final analytic sample consisted of 55 participants (DMT: n = 25; Non-DMT: n = 30), all of whom completed the two-month follow-up assessment and were included in the statistical analyses (Schematic 1). Scheme 1Participant flow diagram showing selection, allocation, follow-up, and analysis. DMT, dance movement therapy Participant flow diagram showing selection, allocation, follow-up, and analysis. DMT, dance movement therapy Experimental procedure To minimize environmental influences on thermoregulation and neuroendocrine responses, the experiment was conducted under controlled climatic conditions (temperature 25.0 ± 0.5 °C, humidity 60.0 ± 3.0%, air velocity 1 m/s). Participant sat in a chair in a relaxed posture for 20 min before the experiment to acclimatize to the chamber and to stabilize body temperature and related physiological responses. Experiments were conducted between 2 pm and 5 pm to reduce the effects of circadian rhythm on body temperature [39]. The DMT intervention was performed three times per week, with each session lasting 90 min. The DMT group (n = 25) completed a total of 24 sessions over 2 months. During the corresponding periods, the Non-DMT control group (n = 30) engaged in quiet routine activities (e.g., reading or desk-based tasks) and were not scheduled to participate in any additional structured physical, therapeutic, or psychosocial programs. Outside the scheduled intervention periods, both groups followed the institution’s standard daily routines. No additional structured exercise, recreational, or therapeutic programs were routinely available during the study period beyond the facility’s usual schedule, minimizing differences in overall activity and psychosocial exposure between groups apart from the DMT intervention. For outcome assessment, BAI scores for psychological analysis and mTb and blood DA concentration as physiological indicators were measured immediately before the first and the 24th DMT sessions in the DMT group. The Non-DMT group underwent the same measurements at corresponding time points (Fig. 1). To reduce potential confounding influences on DA levels and physiological responses, several background conditions were considered. Because all participants resided in the same facility, they were exposed to relatively similar daily schedules, dietary patterns, sleep–wake routines, and environmental conditions, thereby reducing variability in baseline PA, nutrition, and ambient exposure. Information on psychotropic medication use was reviewed as part of eligibility screening, and individuals taking medications known to affect neurochemical or physiological responses were excluded. Menstrual cycle phase was not systematically recorded, given privacy considerations and the sensitivity of collecting this information in the detention setting. However, all assessments were conducted under comparable conditions and within similar timeframes for both groups, which likely minimized intergroup bias. Safety monitoring was conducted throughout all DMT sessions by trained clinical staff. Participants were observed for physical discomfort, emotional distress, behavioral agitation, or fatigue, and vital signs were assessed before and after each session. Any adverse reactions led to immediate pausing or termination of the session, with appropriate supportive care provided. Participation was voluntary, and no serious adverse events occurred. Fig. 1Experimental protocol. Experimental measurement of mean body temperature (mTb: by tympanic temperature and mean skin temperature), blood dopamine (DA) levels, and Beck Anxiety Inventory (BAI) scale. During the intervention, participants in the DMT group engaged in DMT, while the Non-DMT control group remained sedentary, engaging in non-physical activities (e.g., reading). A The DMT intervention was conducted for the DMT group over a two-month period, consisting of 24 sessions. Each session included 20 min of rest followed by 90 min of DMT. Physiological measurements, mTb and blood DA levels, were performed under stable conditions after 20 min of rest before DMT. Physiological measures were administered twice: tests were given before (1st) and after (2nd) the intervention in the first and 24th sessions. Blood samples were taken and analyzed for DA. Psychological assessment using the Beck Anxiety Inventory (BAI) was also conducted at the same two time points. B The same physiological and psychological measurements were performed for the Non-DMT control group at comparable time points (Before and After). DMT, dance movement therapy; mTb, mean body temperature; DA, dopamine; BAI, beck anxiety inventory Experimental protocol. Experimental measurement of mean body temperature (mTb: by tympanic temperature and mean skin temperature), blood dopamine (DA) levels, and Beck Anxiety Inventory (BAI) scale. During the intervention, participants in the DMT group engaged in DMT, while the Non-DMT control group remained sedentary, engaging in non-physical activities (e.g., reading). A The DMT intervention was conducted for the DMT group over a two-month period, consisting of 24 sessions. Each session included 20 min of rest followed by 90 min of DMT. Physiological measurements, mTb and blood DA levels, were performed under stable conditions after 20 min of rest before DMT. Physiological measures were administered twice: tests were given before (1st) and after (2nd) the intervention in the first and 24th sessions. Blood samples were taken and analyzed for DA. Psychological assessment using the Beck Anxiety Inventory (BAI) was also conducted at the same two time points. B The same physiological and psychological measurements were performed for the Non-DMT control group at comparable time points (Before and After). DMT, dance movement therapy; mTb, mean body temperature; DA, dopamine; BAI, beck anxiety inventory Dance/movement therapy (DMT) In this study, the Social Engagement System–DMT (SES–DMT) program was implemented as a structured intervention to reduce anxiety and promote emotional regulation in female adolescents in JDCs. The program, previously shown to be effective in adolescents in JDCs [40], was based on principles of neurological DMT [41] and polyvagal theory [42], and was adapted to the contextual needs and constraints of detention settings. The intervention consisted of 24 sessions, each lasting 90 min. Each session followed a standardized five-step structure: (1) breathing and body awareness exercises to promote relaxation and a sense of safety; (2) sensory and cognitive integration using verbal and nonverbal methods; (3) group mirroring and social engagement; (4) emotion regulation and adaptive interaction; and (5) reflective and integrative movement (Supplementary Table S1). Activities emphasized observable behaviors such as posture, attention to breathing, mirroring peers, and interactive improvisational movement, encouraging participants to express personal experiences through movement rather than relying solely on verbal descriptions of emotion. This design linked the intervention directly to measurable outcomes, including peripheral DA and mTb, which were pre-specified physiological markers to examine potential mechanisms of anxiolytic effects. All sessions were conducted by a licensed dance movement therapist who guided participants through structured and interactive exercises. Intervention fidelity was supported through session checklists, supervision, and continuous observation of participant engagement and distress. The program was specifically adapted for female adolescents in JDCs by accounting for limited space, group dynamics, and the need for safety and emotional containment. To enhance feasibility and safety, activities emphasized observable, low-risk movements, minimized competitive or high-arousal elements, aligned with institutional schedules, and addressed common maladaptive defense strategies observed in this population. Tympanic temperature measurements In the present study, tympanic temperature (Tty) was used as the operational measure of core body temperature. Tympanic temperature (Tty) was assessed in the left ear by inserting a thermistor probe (TSK7 + 1, Songkitopia, Incheon, Korea) with a small spring into the ear canal (TAKARA, Instrument Co. Ltd., Yokohama, Japan). Tympanic temperature was selected because it provides a reliable, minimally invasive estimate of core body temperature and is less affected by external environmental factors compared with oral or axillary measurements [43–46]. It has been widely used as an indirect indicator that approximates core and brain temperature and has been suggested to be associated with cerebral blood flow, autonomic nervous system activity, and hypothalamic thermoregulatory processes [47]. The left ear was used consistently for all participants to standardize the procedure and minimize measurement variability, as previous studies have reported interaural differences in tympanic temperature measurements [48]. The probe was connected to a data logger (model K-720, Technol Seven, Yokohama, Japan) for signal acquisition, and the recorded data were transferred to a personal computer (model CF-T1, Panasonic, Tokyo, Japan) for storage and analysis [39, 43, 44]. The device was used according to the manufacturer’s specifications, and its accuracy was verified prior to the study using a traceable reference standard to ensure measurement reliability. All procedures were conducted in accordance with the approved study protocol and under the supervision of trained personnel. The probe was gently positioned to contact the tympanic membrane near, and a small sterile cotton was placed in the inner pinna to stabilize the probe without occluding the external auditory canal [43–46]. The probe was maintained in position until the device displayed a stable temperature reading under automated continuous measurement, and the recorded value was used for analysis as a 20-second average. Details of the temperature measurement protocol included the thermistor probe attachment method (taping), recording interval (every 20 s), measurement time points (before the intervention: pre- and post-DMT session; after the intervention: pre- and post-DMT session), and stabilization under automated continuous temperature monitoring. Mean body temperature (mTb) and mean skin temperature (mTs) measurements Skin temperatures of eight regions of the skin (chest, upper back, lower back, abdomen, upper arm, forearm, thigh, and leg) were measured with a TSK7 + 1 thermistor probe (Songkitopia, Incheon, Republic of Korea) and a K923 small spring (Takara, Yokohama, Japan) [43]. All measurement procedures, including sensor attachment, stabilization, and data recording, were conducted in accordance with the manufacturer’s specifications and performed under the controlled environmental conditions described above to minimize external influences on thermoregulation and ensure consistency across sessions. For the calculation of mean skin temperature (mTs), the established four-site weighted equation proposed by Ramanathan (1964) was applied as described previously [49], using chest, upper arm, thigh, and leg temperatures. This model was selected because it provides a simplified and widely used approximation of mTb with strong agreement to more complex multi-site weighting systems [45, 46]. The additional sites were recorded for comprehensive monitoring but were not included in the mTs calculation. The mTs was calculated using the following equation: mTs = 0.3 ⋅ (Tschest + Tsupper arm) + 0.2 ⋅ (Tsthigh + Tsleg) [49]. The mTb was calculated using the following formula: mTb = (0.9 ⋅ Tty + 0.1 ⋅ mTs) [49, 50]. Although core temperature contributes predominantly to mTb, inclusion of mTs allows incorporation of peripheral thermal status and provides a more physiologically representative estimate of overall body temperature [43, 44, 49, 50]. No additional averaging procedures were applied beyond the device’s internal processing algorithm. The probe was maintained in position until a stable temperature reading (automated, continuous assessment of the temperatures) was displayed by the device, and this value was recorded (mean of every 20 s) for analysis. Beck anxiety inventory (BAI) Anxiety symptoms were assessed using the Beck Anxiety Inventory (BAI), a 21-item self-report measure of anxiety [51]. The BAI is widely used because of its brevity, simplicity, and utility in assessing general anxiety [52, 53]. Each question was rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (severely), yielding a total score of 0 to 63. Higher scores indicate greater anxiety severity and are classified as minimal (0–7), mild (8–15), moderate (16–25), and severe (26–63). The BAI was self-administered under the supervision of trained research staff, who provided standardized instructions and clarified questions as needed to ensure comprehension and completeness. The Korean version of the BAI has demonstrated strong psychometric properties, including high internal consistency (Cronbach’s α = 0.91–0.93) and test–retest reliability (r = 0.84) [54–56]. In addition, Park & Hoe (2016) confirmed the factor structure and measurement invariance in Korean adolescents [57]. The version used in this study was officially translated and culturally adapted for Korean populations, including sensitivity to the somatic expression of psychological distress [56]. Blood dopamine (DA) analysis Blood samples were collected into EDTA tubes from antecubital veins before applying the 1 st (Before) and the 24th DMT (After). All blood sampling was performed between 2:00 and 5:00 pm under controlled environmental conditions (25.0 ± 0.5 °C; humidity 60.0 ± 3.0%) following a standardized seated rest period to minimize diurnal and activity-related variability. Samples were gently inverted to ensure proper anticoagulation and immediately centrifuged at 3000 rpm (2000 ×g) for 10 min at 4 °C. Plasma was harvested and stored at − 80 °C until analysis. DA levels were determined using high-performance liquid chromatography (HPLC) with the Plasma Catecholamine Kit (Bio-Rad, Germany) in combination with the Acclaim HPLC system (Bio-Rad, USA) [58]. Values below this limit were assumed to be zero for the statistical analysis. Given the small number of such values, this approach was unlikely to materially influence the overall results. The inter- and intra-assay coefficients of variance were < 10% [58]. Statistical analysis Values are presented as mean ± standard deviation (SD). Statistical analyses were performed using a commercially available computer software SPSS for Windows, version 21.0 (SPSS Inc., Chicago, IL, USA). Independent-samples t-tests and paired-samples t-tests were used to assess between-group and within-group differences, respectively. Assumptions of normality and homogeneity of variance were evaluated prior to parametric analyses. Pearson correlation coefficients and linear regression analyses were used to examine associations between variables. Statistical significance was set at p < 0.05. Because the analyses were limited to predefined primary variables and mechanistically related correlations, formal adjustment for multiple comparisons was not applied in the primary analyses. However, as a sensitivity analysis, Bonferroni correction was additionally examined, and all primary outcomes remained statistically significant (adjusted α = 0.017; all p < 0.001; see Supplementary Table S2). Results Baseline demographic characteristics and outcome measures (BAI, mTb, and blood DA levels) did not significantly differ between participants who completed the study and those who withdrew during the intervention period. Therefore, the final analyses were conducted using data from participants who completed the study. Increase in mTb Changes in mTb of the Non-DMT group (n = 30) and the DMT group (n = 25) were evaluated. Prior to DMT, the two groups exhibited comparable levels of mTb (Non-DMT group 36.40 ± 0.20 °C vs. DMT group 36.39 ± 0.24 °C). Changes in mTb for the Non-DMT group and the DMT group before and after DMT are presented in Fig. 2A; Table 2. In the case of the Non-DMT group, changes in mTb after 8 weeks were not significant. On the contrary, mTb in the DMT group was significantly increased after DMT (before 36.39 ± 0.24 °C vs. after 36.50 ± 0.22 °C, ***p < 0.001). Figure 2B displays individual differences in mTb within the DMT group. After the intervention, mTb differed significantly between the control and DMT groups (Non-DMT group 36.40 ± 0.18 °C vs. DMT group 36.50 ± 0.22 °C, #p < 0.05), with the DMT group showing a greater increase in mTb. Fig. 2Comparison of mTb between the Non-DMT group and the DMT group before and after DMT. Values (n = 55) are presented as mean ± SD. A The mean body temperature (mTb) in the DMT group had increased significantly compared to the Non DMT group after DMT (Non-DMT group 36.40 ± 0.18 °C vs. DMT group 36.50 ± 0.22 °C, #p < 0.05). Significantly increased mTb in the DMT group after DMT (before 36.39 ± 0.24 °C vs. after 36.50 ± 0.22 °C, ***p < 0.001). B Changes of mTb (Increased ▲ of 0.11 ± 0.07 °C) by each participant before and after DMT in DMT group (n = 25, ***p < 0.001). DMT, dance movement therapy; Non-DMT G, Non-DMT group; DMT G, DMT group Comparison of mTb between the Non-DMT group and the DMT group before and after DMT. Values (n = 55) are presented as mean ± SD. A The mean body temperature (mTb) in the DMT group had increased significantly compared to the Non DMT group after DMT (Non-DMT group 36.40 ± 0.18 °C vs. DMT group 36.50 ± 0.22 °C, #p < 0.05). Significantly increased mTb in the DMT group after DMT (before 36.39 ± 0.24 °C vs. after 36.50 ± 0.22 °C, ***p < 0.001). B Changes of mTb (Increased ▲ of 0.11 ± 0.07 °C) by each participant before and after DMT in DMT group (n = 25, ***p < 0.001). DMT, dance movement therapy; Non-DMT G, Non-DMT group; DMT G, DMT group Table 2Changes in dopamine, BAI, and mTb between the DMT and control groupsVariablesGroupBefore95% CI(lower to upper)After95% CI(lower to upper)Dopamine (pg/mL)Control13.67 ± 6.782.53 (11.14 to 16.20)14.00 ± 6.312.36 (11.64 to 16.36)DMT G13.64 ± 7.453.08 (10.57 to 16.72)17.68 ± 8.94#, ***3.69 (13.99 to 21.37)BAI (scores)Control34.52 ± 8.243.08 (31.44 to 37.59)34.00 ± 7.432.78 (31.23 to 36.78)DMT G35.46 ± 8.213.39 (32.07 to 38.85)29.95 ± 6.58#, ***2.71 (27.24 to 32.67)mTb (oC)Control36.40 ± 0.200.08 (36.32 to 36.47)36.40 ± 0.180.07 (36.34 to 36.47)DMT G36.39 ± 0.240.10 (36.29 to 36.49)36.50 ± 0.22#,***0.09 (36.41 to 36.59)Values (n = 55) are presented as mean ± SD. A statistically significant difference in dopamine, beck anxiety inventory (BAI) and mean body temperature (mTb) was observed between the control (Non-DMT group, n = 30) and DMT G (DMT group, n = 25). #p < 0.05 indicates a significant difference between the control and DMT groups. ***p < 0.001 indicates a significant within-group difference (before vs. after). The 95% CI differ from before and after in the DMT (dance movement therapy). Application of DMT ***p < 0.001. CI (confidence intervals), 95% CI (lower limit to upper limit). † 95% CI was calculated using the Student’s t-distribution: 95% CI margin = t(df = n−1, 0.025) × SD/√n equivalent to Excel CONFIDENCE.T(0.05, SD, n). The narrow CIs observed for mean body temperature (SD ≈ 0.20–0.24 °C) reflect the tight physiological homeostasis of core body temperature, not a calculation error. BAI and dopamine measurements show wider CIs consistent with greater inter-individual variability Table 2Changes in dopamine, BAI, and mTb between the DMT and control groupsVariablesGroupBefore95% CI(lower to upper)After95% CI(lower to upper)Dopamine (pg/mL)Control13.67 ± 6.782.53 (11.14 to 16.20)14.00 ± 6.312.36 (11.64 to 16.36)DMT G13.64 ± 7.453.08 (10.57 to 16.72)17.68 ± 8.94#, ***3.69 (13.99 to 21.37)BAI (scores)Control34.52 ± 8.243.08 (31.44 to 37.59)34.00 ± 7.432.78 (31.23 to 36.78)DMT G35.46 ± 8.213.39 (32.07 to 38.85)29.95 ± 6.58#, ***2.71 (27.24 to 32.67)mTb (oC)Control36.40 ± 0.200.08 (36.32 to 36.47)36.40 ± 0.180.07 (36.34 to 36.47)DMT G36.39 ± 0.240.10 (36.29 to 36.49)36.50 ± 0.22#,***0.09 (36.41 to 36.59)Values (n = 55) are presented as mean ± SD. A statistically significant difference in dopamine, beck anxiety inventory (BAI) and mean body temperature (mTb) was observed between the control (Non-DMT group, n = 30) and DMT G (DMT group, n = 25). #p < 0.05 indicates a significant difference between the control and DMT groups. ***p < 0.001 indicates a significant within-group difference (before vs. after). The 95% CI differ from before and after in the DMT (dance movement therapy). Application of DMT ***p < 0.001. CI (confidence intervals), 95% CI (lower limit to upper limit). † 95% CI was calculated using the Student’s t-distribution: 95% CI margin = t(df = n−1, 0.025) × SD/√n equivalent to Excel CONFIDENCE.T(0.05, SD, n). The narrow CIs observed for mean body temperature (SD ≈ 0.20–0.24 °C) reflect the tight physiological homeostasis of core body temperature, not a calculation error. BAI and dopamine measurements show wider CIs consistent with greater inter-individual variability Changes in dopamine, BAI, and mTb between the DMT and control groups Values (n = 55) are presented as mean ± SD. A statistically significant difference in dopamine, beck anxiety inventory (BAI) and mean body temperature (mTb) was observed between the control (Non-DMT group, n = 30) and DMT G (DMT group, n = 25). #p < 0.05 indicates a significant difference between the control and DMT groups. ***p < 0.001 indicates a significant within-group difference (before vs. after). The 95% CI differ from before and after in the DMT (dance movement therapy). Application of DMT ***p < 0.001. CI (confidence intervals), 95% CI (lower limit to upper limit). † 95% CI was calculated using the Student’s t-distribution: 95% CI margin = t(df = n−1, 0.025) × SD/√n equivalent to Excel CONFIDENCE.T(0.05, SD, n). The narrow CIs observed for mean body temperature (SD ≈ 0.20–0.24 °C) reflect the tight physiological homeostasis of core body temperature, not a calculation error. BAI and dopamine measurements show wider CIs consistent with greater inter-individual variability Reduction in BAI scores While comparing BAI levels of the two groups before DMT, there was no significant difference between them (Non-DMT group 34.52 ± 8.24 vs. DMT group 35.46 ± 8.21). Changes in BAI score for the Non-DMT group and the DMT group before and after DMT are presented in Fig. 3A; Table 2. In the DMT group, the BAI score was significantly decreased after DMT compared to the control (Non-DMT group 34.00 ± 7.43 vs. DMT group 29.95 ± 6.58, #p < 0.05). There was a statistically significant difference in BAI score of the DMT group before and after DMT (before: 35.46 ± 8.21 vs. after: 29.95 ± 6.58, ***p < 0.001). Fig. 3Comparison of BAI scores and blood dopamine concentration between the Non-DMT group and the DMT group before and after DMT. Values (n = 55) are presented as mean ± SD. A The Beck Anxiety Inventory (BAI) scores in the DMT group was significantly decreased after DMT compared to the Non-DMT group (Non-DMT group 34.00 ± 7.43 vs. DMT group 29.95 ± 6.58, #p < 0.05). Statistically significant difference in BAI scores of the DMT group before and after DMT (before: 35.46 ± 8.21 vs. after: 29.95 ± 6.58, ***p < 0.001). B Blood dopamine level of the DMT group was significantly increased after DMT compared to the Non-DMT group (Non-DMT group 14.00 ± 6.31 pg/mL vs. DMT group 17.68 ± 8.94 pg/mL, #p < 0.05). Statistically significant difference in blood dopamine level of the DMT group before and after DMT (before: 13.64 ± 7.45 pg/mL vs. after: 17.68 ± 8.94 pg/mL, ***p < 0.001). DMT, dance movement therapy; Non-DMT G, Non-DMT group; DMT G, DMT group Comparison of BAI scores and blood dopamine concentration between the Non-DMT group and the DMT group before and after DMT. Values (n = 55) are presented as mean ± SD. A The Beck Anxiety Inventory (BAI) scores in the DMT group was significantly decreased after DMT compared to the Non-DMT group (Non-DMT group 34.00 ± 7.43 vs. DMT group 29.95 ± 6.58, #p < 0.05). Statistically significant difference in BAI scores of the DMT group before and after DMT (before: 35.46 ± 8.21 vs. after: 29.95 ± 6.58, ***p < 0.001). B Blood dopamine level of the DMT group was significantly increased after DMT compared to the Non-DMT group (Non-DMT group 14.00 ± 6.31 pg/mL vs. DMT group 17.68 ± 8.94 pg/mL, #p < 0.05). Statistically significant difference in blood dopamine level of the DMT group before and after DMT (before: 13.64 ± 7.45 pg/mL vs. after: 17.68 ± 8.94 pg/mL, ***p < 0.001). DMT, dance movement therapy; Non-DMT G, Non-DMT group; DMT G, DMT group Increase in blood DA levels In the analysis of blood DA concentration (Fig. 3B; Table 2), there was no significant difference between the two groups before DMT (Non-DMT group 13.67 ± 6.78 pg/mL vs. DMT group 13.64 ± 7.45 pg/mL). After DMT in the DMT group, blood DA concentration was significantly increased, however, the difference after 8 weeks was not significant in the control group (Non-DMT group 14.00 ± 6.31 pg/mL vs. DMT group 17.68 ± 8.94 pg/mL, #p < 0.05). The change in DA concentration of the DMT group before and after DMT was statistically significant (before: 13.64 ± 7.45 pg/mL vs. after: 17.68 ± 8.94 pg/mL, ***p < 0.001). Correlations between mTb, BAI, and DA levels In the DMT group (n = 25), which showed significant changes before and after the intervention, correlations among the measured parameters were analyzed. As shown in Fig. 4A, mTb was negatively associated with BAI scores both before DMT (R = −0.760, ***p < 0.001) and after DMT (R = −0.759, ***p < 0.001). The relationships of blood DA concentration with mTb and BAI in the DMT group are presented in Fig. 4B and C. Blood DA concentration showed a positive association with mTb both before DMT (R = 0.696, ***p < 0.001) and after DMT (R = 0.772, ***p < 0.001). In contrast, BAI scores were negatively associated with blood DA concentration both before DMT (R = −0.671, ***p < 0.001) and after DMT (R = −0.705, ***p < 0.001). Fig. 4Correlation between mTb, blood dopamine concentration and BAI scores before and after DMT in DMT group. A Correlation between mTb (mean body temperature) and BAI (Beck Anxiety Inventory) scores. B Correlation between mTb and blood dopamine concentration. C Correlation between BAI scores and blood dopamine concentration. DMT, dance movement therapy Correlation between mTb, blood dopamine concentration and BAI scores before and after DMT in DMT group. A Correlation between mTb (mean body temperature) and BAI (Beck Anxiety Inventory) scores. B Correlation between mTb and blood dopamine concentration. C Correlation between BAI scores and blood dopamine concentration. DMT, dance movement therapy Discussion Anxiety commonly emerges during adolescence [59], a period marked by ongoing maturation of amygdala–prefrontal circuits involved in anxiety-related behaviors [60, 61]. Most mental disorders, including anxiety and depression, begin during adolescence, underscoring the importance of early prevention to reduce progression into adulthood [7, 62]. These issues may be especially pronounced in adolescents in juvenile detention settings, where restricted freedom, social isolation, and uncertainty about the future may intensify emotional distress. Arts-based psychotherapies, such as art therapy [63], music therapy [64], and DMT [14], have been explored as non-pharmacological interventions for adolescent mental disorders. DMT integrates structured PA with emotional expression and interpersonal interaction and has been shown to reduce anxiety symptoms [10]. In this study, adolescents participated in a DMT intervention or were in a Non-DMT control group. Compared with the Non-DMT group, the DMT group showed significant improvements in anxiety, accompanied by increased blood DA levels and significant associations among BAI, DA, and mTb. Dopaminergic associations with anxiety Blood DA concentration in the DMT group increased by 30% relative to baseline (p < 0.001; 95% CI, 13.99 to 21.37), with an effect size of Cohen’s d_av = 0.49 (Supplementary Table S3), consistent with previous studies indicating that PA and exercise can influence dopaminergic function [25, 65]. Because DMT combines structured movement with rhythmic, expressive, and socially interactive elements [15, 16], it may engage reward- and affect-related processes relevant to anxiety reduction [17]. A negative correlation between BAI scores and blood DA levels was also observed (Fig. 4C), suggesting that higher peripheral DA levels are associated with lower anxiety symptoms in the DMT group. This is consistent with previous studies showing that activation of the dopaminergic system and increased DA levels may alleviate anxiety [23, 29], as the mesolimbic, mesocortical, and nigrostriatal pathways are key circuits involved in anxiety regulation [29]. DA plays an important role in reward and motivation processes, and the rhythmic and expressive movements involved in DMT may help engage these systems in ways relevant to emotional release and anxiety reduction. For adolescents in JDCs, where autonomy and sensory stimulation are often limited, such reward-related engagement may be particularly salient. However, DA was measured in peripheral blood rather than the central nervous system, and circulating levels do not directly reflect synaptic dopaminergic transmission. Plasma DA may also be influenced by peripheral metabolism and sympathetic or adrenal activity. Therefore, these findings should be interpreted as indirect psychophysiological associations rather than direct evidence of central dopaminergic mechanisms. Despite this limitation, the observed association may still be informative at the systemic level. In this context, peripheral biomarkers may provide a more feasible and less invasive approach for exploratory psychophysiological research than neuroimaging or cerebrospinal fluid analyses analyses [66]. Participation in DMT may promote emotional engagement and expression through movement and interpersonal interaction, processes that may be linked to integrated psychophysiological responses relevant to anxiety regulation. PA-related dopaminergic activation has been associated with mood enhancement and improved stress resilience [26], which may further support self-efficacy and emotional regulation [67]. In addition, synchrony, mirroring, and expressive interaction in DMT [15] may strengthen social connectedness and emotional attunement, potentially amplifying reward-related neurochemical responses [16, 17]. Together, these findings suggest that DMT participation is associated with lower anxiety and higher peripheral DA levels, although the underlying neurobiological mechanisms require further investigation. Thermoregulatory responses and anxiety In the DMT group, increased blood DA levels were associated with elevated mTb, with mTb rising as DA levels increased (Fig. 4B). This suggests a potential link between dopaminergic activity, physical exercise, and thermoregulatory processes [27, 68]. Previous studies have reported that stimulation of dopaminergic reward pathways, particularly the nigrostriatal and mesocorticolimbic systems, is associated with changes in exercise performance and core body temperature in animal models [69]. Another possible explanation involves autonomic and metabolic activation. As a form of PA, DMT may stimulate sympathetic and thermogenic processes, increasing energy expenditure and heat production [46, 70]. A significant increase in mTb of 0.11 ± 0.07 °C was observed in the DMT group following the intervention (p < 0.001; 95% CI, 36.41 to 36.59; Cohen’s d_av = 0.48), whereas no comparable change was observed in the Non-DMT group. Although the increase was numerically small, its relevance lies in the timing and pattern of the change rather than its absolute value. Specifically, mTb was measured during a resting state immediately before the first DMT session and again during a resting state immediately before the 24th session. Thus, the increase in the DMT group is unlikely to reflect only an acute movement- or exercise-related heat response. It may indicate a cumulative shift in resting thermophysiological regulation following repeated DMT participation (Supplementary Table S4; Supplementary Fig. 1). Even modest increases in resting body temperature may be meaningful at the psychophysiological level. Body temperature reflects an interoceptive aspect of physiological state [71] and may also indicate subtle adaptations in thermophysiological and autonomic regulation [72]. Within the framework of the thermogenic hypothesis, this change may represent one component of a coordinated psychophysiological pattern associated with reduced anxiety [73, 74]. As noted above, the observed increase in mTb may also be associated with dopaminergic activation induced by DMT. Beyond this, DMT has been reported to enhance social interaction and empathy [16, 75], processes often discussed in relation to oxytocin signaling [76]. Oxytocin has been shown to modulate dopaminergic activity within reward-related circuits, including the ventral tegmental area, and may contribute to social motivation, stress regulation [77, 78], and thermogenic responses through hypothalamic pathways [79, 80]. Although neither oxytocin levels nor central neural activity were measured in this study, these mechanisms may contribute to the observed mTb increase and its relevance to social bonding and empathic processes. However, this interpretation remains speculative and requires further empirical investigation. Notably, mTb was negatively correlated with BAI scores, indicating that higher body temperature was associated with lower anxiety levels (Fig. 4A). This finding is broadly consistent with the thermogenic hypothesis, which proposes that increases in body temperature may contribute to anxiolytic effects through interacting physiological and psychological mechanisms. According to this framework, exercise- or movement-related thermogenic responses may reduce anxiety through mechanisms such as reduced muscular tension, altered neuronal activity, affective improvement, and modulation of stress-related neurobiological systems, including neurotransmitter function and hypothalamic–pituitary–adrenal axis regulation [34, 73, 74]. Thus, the negative association between mTb and BAI scores supports the idea that thermoregulatory responses may be linked to emotional state and anxiety reduction. However, empirical support for the thermogenic hypothesis remains mixed, and some studies have reported inconsistent findings regarding the relationship between body temperature and anxiety [74, 81, 82]. Therefore, the present findings should not be interpreted as evidence of a direct causal pathway between increased resting mTb and reduced anxiety. Rather, the increase in resting mTb may reflect a psychophysiological adaptation associated with symptom improvement. Integrated psychophysiological interpretation of the findings Consistent with this interpretation, BAI scores in the DMT group decreased significantly from baseline by 16% (p < 0.001; 95% CI, 27.24 to 32.67; Cohen’s d_av = −0.74), indicating a moderate-to-large within-group effect. Post-intervention anxiety levels were also lower in the DMT group than in the Non-DMT group. Significant concurrent changes were observed in peripheral DA and mTb (Cohen’s d_av = 0.49 and 0.48, respectively) (Supplementary Table S3). This pattern aligns with our hypothesis that DMT would reduce anxiety and produce associated changes in DA and mTb among adolescents in JDCs (Fig. 5). The reduction in anxiety symptoms represents the most directly clinically interpretable outcome of the intervention, while the concurrent changes in peripheral DA and mTb provide insight into the underlying psychophysiological processes associated with DMT. Effect sizes for post-intervention changes in anxiety, peripheral DA, and mTb within the DMT group further suggest that DMT may have produced meaningful psychophysiological changes in this correctional setting. Fig. 5Graphical Overview of the Hypothetical Mechanism. DMT as a psychotherapeutic PA holds potential for reducing anxiety. Movement- and reward-based somatic mechanisms in DMT may activate dopaminergic pathways associated with anxiety regulation, leading to increased DA levels and elevated body temperature, which is also due to energy expenditure during movement, both of which may contribute to anxiety reduction. DMT also promotes emotional benefits, contributing to anxiety reduction by enhancing self-efficacy and emotional relief through increased enjoyment, self-expression, empathy, and social connectedness. These psychophysiological effects are reflected in a decrease in BAI scores. DMT, dance movement therapy; PA, physical activity; DA, dopamine; mTb, mean body temperature; Positive SA, positive self-awareness; PFC, prefrontal cortex; NAc, nucleus accumbens; AMG, amygdala; HPC, hippocampus; VTA, ventral tegmental area; SN, substantia nigra; DSTR, dorsal striatum; nigrostriatal (1), mesolimbic (2), mesocortical (3) dopaminergic pathways; BAI, beck anxiety inventory Graphical Overview of the Hypothetical Mechanism. DMT as a psychotherapeutic PA holds potential for reducing anxiety. Movement- and reward-based somatic mechanisms in DMT may activate dopaminergic pathways associated with anxiety regulation, leading to increased DA levels and elevated body temperature, which is also due to energy expenditure during movement, both of which may contribute to anxiety reduction. DMT also promotes emotional benefits, contributing to anxiety reduction by enhancing self-efficacy and emotional relief through increased enjoyment, self-expression, empathy, and social connectedness. These psychophysiological effects are reflected in a decrease in BAI scores. DMT, dance movement therapy; PA, physical activity; DA, dopamine; mTb, mean body temperature; Positive SA, positive self-awareness; PFC, prefrontal cortex; NAc, nucleus accumbens; AMG, amygdala; HPC, hippocampus; VTA, ventral tegmental area; SN, substantia nigra; DSTR, dorsal striatum; nigrostriatal (1), mesolimbic (2), mesocortical (3) dopaminergic pathways; BAI, beck anxiety inventory Strengths, limitations, and future directions A major strength of this study is the integration of standardized psychological measures with physiological biomarkers, including peripheral DA and mTb, within a juvenile detention setting. This multimodal approach enhances ecological validity and provides convergent psychophysiological evidence for DMT effects. Several limitations should be considered when interpreting the findings. First, the study was conducted in a single juvenile detention center and included only female adolescents from a single national and ethnic background, which limits generalizability. Juvenile facilities are typically sex-segregated, and the study was not designed to assess sex differences. Although the proposed mechanisms may not be inherently sex-specific, hormonal and stress-related differences during adolescence could influence responses. Therefore, the present findings should be regarded as preliminary evidence from female detained adolescents, and extrapolation to male adolescents should be made with caution until confirmed by future research. Second, the sample size was relatively small due to institutional constraints and COVID-19 related restrictions. Despite the a priori power analysis and near-target final sample, the restricted research environment and differential attrition, particularly in the DMT group, may have reduced statistical power and affected the stability of the observed estimates. Third, because DA was assessed peripherally, the observed changes should be interpreted cautiously as indirect physiological markers rather than direct indicators of central dopaminergic neurotransmission. Future studies should include multi-site recruitment with larger and more diverse samples based on prospective power analyses, as well as longitudinal follow-up to assess reproducibility and potential sex differences. The use of multimodal assessments, such as neuroimaging, autonomic indices, metabolic parameters, and hormonal markers, could further clarify the underlying mechanisms of DMT effects. Conclusion DMT, which engages the mind–body connection through movement, artistic expression, and empathetic interaction, may help reduce anxiety among adolescents in JDCs. Anxiety improvements were accompanied by physiological changes, including elevated mTb and peripheral DA levels, although causality cannot be inferred. Although limited by a single-site, female-only, small sample, these preliminary findings suggest that structured interventions such as DMT may support mental well-being under restricted conditions. Future research should replicate these results in larger, multi-site studies with more diverse samples and further examine the applicability of DMT in juvenile detention settings. Supplementary Material Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3. Supplementary Material 4. Supplementary Material 4. Supplementary Material 5. Supplementary Material 5.